Home › Funds › Auour Investments LLC › AVIR
Auour Investments LLC position in AVIR
ATEA PHARMACEUTICALS INC · Health Care
Auour Investments LLC reported holding 172,000 shares of AVIR (ATEA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$896K, representing 0.25% of its reported portfolio and ranking #44 among its reported holdings. Auour Investments LLC has disclosed AVIR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Auour Investments LLC's AVIR position evolved
Auour Investments LLC first disclosed a stake in AVIR in Q3 2023 at 177,000 shares (US$535K). The position peaked in Q1 2026 at 177,000 shares, worth US$952K. Across 13 filings, Auour Investments LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 172,000 shares valued at US$896K — a reduction of -5,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 177.00K | $534.54K | New |
| Q4 2023 | 177.00K | $670.83K | Hold |
| Q1 2024 | 177.00K | $715.08K | Hold |
| Q2 2024 | 177.00K | $585.87K | Hold |
| Q3 2024 | 177.00K | $600.03K | Hold |
| Q4 2024 | 177.00K | $541.62K | Hold |
| Q1 2025 | 177.00K | $522.15K | Hold |
| Q2 2025 | 177.00K | $637.20K | Hold |
| Q3 2025 | 177.00K | $513.30K | Hold |
| Q4 2025 | 177.00K | $631.89K | Hold |
| Q1 2026 | 177.00K | $952.26K | Hold |
| Q2 2026 | 177.00K | $823.05K | Hold |
| Q3 2026 | 172.00K | $896.12K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AVIR and 13F data
AVIR (ATEA PHARMACEUTICALS INC) is a Health Care company. 30 other funds we track also report a position in AVIR — the largest reported positions include BML Capital Management, LLC (US$35.2M), TANG CAPITAL MANAGEMENT LLC (US$22.4M), Bain Capital Life Sciences Investors, LLC (US$9.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AVIR
- BML Capital Management, LLC 6.75M sh · $35.19M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 4.81M sh · $22.39M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 2.08M sh · $9.65M · Q2 2026
- Rosalind Advisors, Inc. 1.07M sh · $4.98M · Q2 2026
- Royal Palms Capital LLC 71.13K sh · $2.82M · Q3 2026
- CM Management, LLC 450.00K sh · $2.34M · Q3 2026
More on Auour Investments LLC
FAQ
How long has Auour Investments LLC held AVIR?
Auour Investments LLC has disclosed AVIR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Auour Investments LLC's current position in AVIR?
As of Q3 2026, Auour Investments LLC holds 172.00K shares of AVIR (ATEA PHARMACEUTICALS INC), valued at $896.12K, representing 0.25% of its reported portfolio and ranking #44.
Has Auour Investments LLC been buying or selling AVIR?
In the latest 13F filing (Q3 2026), Auour Investments LLC reduced its position in AVIR. The position peaked in Q1 2026 at 177.00K shares.
Which other funds hold AVIR?
Other major institutional holders of AVIR include BML Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Bain Capital Life Sciences Investors, LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.